The FRED X Flow Diverter is the Next Generation in Flow Diversion TechnologySAN DIEGO & ALISO VIEJO, Calif.--(BUSINESS WIRE)--#microvention--MicroVention, Inc.,...
NEWPORT BEACH, CA / ACCESSWIRE / July, 31 2023 / Wearable Health Solutions, Inc. (OTC:WHSI), a provider of innovative personal...
Updates help states, health plans, managed care organizations and long-term care facilities achieve inclusive, equitable and person-centered careWASHINGTON, DC /...
MicroVention’s WEB System is the World Leader and Only PMA-Approved Intrasaccular Flow Disruptor; Advances Treatment of Wide-Neck Bifurcation Aneurysms with...
Healthcare Providers Report Nym’s Engine Improves Revenue Cycle Efficiency and Reduces Labor Costs by Accurately and Instantly Automating Medical CodingNEW...
Cloud-based solution advances personalized healthcare through scalable, personalized 3D solutions driven by artificial intelligence.BELFAST, Northern Ireland--(BUSINESS WIRE)--#healthcareAI--Axial3D, a leader in...
CAESAREA, ISRAEL / ACCESSWIRE / July 31, 2023 / Marpe Technologies, a leading innovator in dermatology screening solutions, is thrilled...
Multiple Research Studies Are In Official Application Stage For EPW Curesearch Sites Covering Numerous Protocols And SpecialtiesVANCOUVER, BC / ACCESSWIRE...
Harris Poll/Icario Survey Also Finds That 55% of Members 65-Plus Said Their Plan Hasn't Reached Out to ThemMINNEAPOLIS, July 31,...
Distinguished Healthcare Leader Dave Wichmann and Seasoned CHRO Pam Kimmet to Join BoardARLINGTON, Va., July 31, 2023 (GLOBE NEWSWIRE) --...
CINCINNATI, July 31, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology...
- Results Confirm that Trilaciclib Reduces Single and Multilineage Grade ≥3 Myelosuppressive Hematologic Adverse Events (HAEs) Including Neutropenia, Anemia, and...
Dr. Tatyana Morton Dr. Tatyana Morton, Ovation Private HealthNEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- Tatyana Z. Morton, M.D.,...
Phase 3 PIVOT-PO trial is expected to begin with First Patient, First Visit in 4Q 2023 Spero to receive $30...
CAMBRIDGE, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan Oncology”) a biopharmaceutical company focused on...
Latest data details how Medicare Advantage company drove greater reduction in members’ blood sugar levels and diabetes-related deaths, provided more...
Niagara Falls, NY, July 31, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular...
Media Release Late-stage & registrational trial progress: TACTI-004 Phase III - Positive feedback received from US FDA for planned registrational...
PALO ALTO, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180LS” or the “Company”), today...
89% and 84% of patients were maintained on ≥12- and ≥16-week dosing intervals, respectively, throughout the two-year period, while sustaining their...